|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||||
  Headache: The Journal of Head and Face PainVolume 31 Issue 9, Pages 601 - 604 Published Online: 20 May 2005 © 2010 American Headache Society Published on behalf of the American Headache Society
Abstract | Full Text: PDF (Size: 147K) | Related Articles | Citation Tracking  Treatment of Tension-type Headache With Tizanidine Hydrochloride: Its Efficacy and Relationship to the Plasma MHPG Concentration Copyright © 1991 American Headache Society (formerly the American Association for the Study of Headache) KEYWORDS tension headache • tizanidine • autonomic • sympathetic • MHPG ABSTRACTSYNOPSIS Seventy-eight patients with tension-type headache (TH) were treated with tizanidine hydrochloride(tizanidine). Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and serum free fatty acids (FFA) levels in thesepatients were determined before the treatment with tizanidine. Eighteen healthy volunteers composed thecontrol group. Four weeks after the treatment with tizanidine 24 (31%) of 78 patients showed excellentimprovement (excellent group); 28 (35%) showed moderate improvement (moderate group); 18 (23%) showedmild improvement (mild group); 7 (10%) showed no improvement and one (1%) showed worsening of herheadache (no change and worsened group). The plasma MHPG levels in the excellent group were significantlyhigher than in the other groups, including the control group. The serum FFA levels in the excellent group weresignificantly higher than in the controls.In this study, 66% of the patients reported improvement in their headaches. Some patients with TH had highplasma MHPG levels and these patients in particular showed excellent improvement after the administration oftizanidine. Though there may be a placebo response to some extent, the clinical usefulness of tizanidine for THseems to be excellent. Further study is necessary concerning the pharmacological effect of tizanidine andplasma MHPG levels in patients with TH. Accepted for Publication: September 13, 1991. | 
|
